Reference

Antisnoring agent

Antisnoring agent. Reichert, Dietrich (Spain ). Ger. Offen. DE 3317530 A1 15 Nov 1984,17 pp. (German). (Germany). CODEN: GWXXBX. CLASS: IC: A61K045-06; A61K031-135; A61K031-495; A61K031-705; A61K031-195; A61K035-78; A61K031-025; A61K031-16; A61K031-14. APPLICATION: DE 83-3317530 13 May 1983. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) An antisnoring agent for topical application to the nose or throat contains a secretolytic together with mucous membrane-compatible carriers or diluents. The compns. are in spray or inhalation soln. forms. The active secretolytics regulate and normalize mucus viscosity, decrease mucus adhesion by activation of surfactant properties, stimulate serous mucus prodn., and activate the mucociliary function. A nasal compn. was prepd. from a mixt. of ambroxol-HCl [23828-92-4] 10.0, glycerol [56-81-5] 1.0 mL, benzalkonium chloride 1.0 g and physiol. saline soln. to 100 mL for 1/2 - 1 mL doses.

Oral antisnoring agent

Oral antisnoring agent. Reichert, Dietrich (Spain ). Ger. Offen. DE 3317558 A1 15 Nov 1984,17 pp. (German). (Germany). CODEN: GWXXBX. CLASS: IC: A61K045-06; A61K031-135; A61K031-495; A61K031-705; A61K031-195; A61K009-58; A61K035-78; A61K031-07; A61K031-355. APPLICATION: DE 83-3317558 13 May 1983. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) An oral antisnoring agent contains compds. with secretolytic effects or effects on mucous-membrane secretion prodn., carriers and diluents. The active compd. regulate and normalize mucus viscosity, decrease mucus adhesion by activating surfactant properties of the secretion, stimulation of mucus prodn., and activate the mucociliary function. Capsules were prepd. from a mixt. of ambroxol-HCl [23828-92-4] 10.0, cornstarch 24.0, and Aerosil 200 0.4 g; each capsule contained 170 mg mixt.